Emerg Infect Dis. 2024 Aug;30(8):1692-1696. doi: 10.3201/eid3008.231596.
Before the COVID-19 pandemic, Mycoplasma pneumoniae infections emerged during spring to summer yearly in Taiwan, but infections were few during the pandemic. M. pneumoniae macrolide resistance soared to 85.7% in 2020 but declined to 0% during 2022-2023. Continued molecular surveillance is necessary to monitor trends in macrolide-resistant M. pneumoniae.
在 COVID-19 大流行之前,台湾每年春季至夏季都会出现肺炎支原体感染,但大流行期间感染病例很少。2020 年肺炎支原体大环内酯类耐药率飙升至 85.7%,但在 2022-2023 年降至 0%。需要持续进行分子监测,以监测大环内酯类耐药肺炎支原体的趋势。